Hyperthermic intraperitonal chemotherapy is an independent risk factor for development of acute kidney injury.
Dagel T, Misirlioglu S, Tanju S, Afsar B, Selcukbiricik F, Erus S, Vatansever D, Balik E, Taskiran C, Dilege S, Molinas Mandel N, Bugra D, Yalti T, Kanbay M.
Dagel T, et al. Among authors: selcukbiricik f.
J BUON. 2018 Sep-Oct;23(5):1528-1533.
J BUON. 2018.
PMID: 30570881
Free article.